Biolase appoints chief financial, operating officers
Biolase (Nasdaq:BIOL) announced today that it appointed Jennifer Bright as its new CFO and Steven Sandor as its new COO.
Stay updated with breaking news from John Beaver. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biolase (Nasdaq:BIOL) announced today that it appointed Jennifer Bright as its new CFO and Steven Sandor as its new COO.
(RTTNews) - Medical device company BIOLASE, Inc. (BIOL) announced Thursday the appointments of Jennifer Bright to Chief Financial Officer and Stev...
/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced a partnership today with TeamSmile. This partnership will provide...
/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced that, on June 30, 2022, it entered into an amendment to its senior...
/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced that, on June 30, 2022, it entered into an amendment to its senior...